HOME >> MEDICINE >> NEWS
Scripps Research awarded $17 million for adult stem cell use to treat eye diseases

"We're extremely excited about this grant and by the confidence peer review and the NEI has placed in our project," said the initiatives principal investigator Martin Friedlander, a professor at Scripps Research and retina specialist at Scripps Clinic. "Our goal in the next five years is to develop this new approach to treating retinal diseases to the point it can be tested in the clinic. The project addresses a large unmet medical need-developing new treatments for patients who are losing their sight due to neovascular and retinal degenerative diseases."

Under the auspices of the new grant, titled "Adult Stem Cells for Therapy of Visual Disorders," the Friedlander lab will work with six other laboratory groups at Scripps Research-those of Laura Crisa, Glen Nemerow, Wolfram Ruf, Gary Siuzdak, Bruce Torbett, and William Balch. Together, this team will conduct the extensive and detailed pre-clinical work necessary for moving the potential therapy forward. The project will also explore novel technologies and approaches to understanding and developing treatments for retinal vascular and degenerative diseases, including diabetic retinopathy, age related macular degeneration, glaucoma, and retinitis pigmentosa.

A Promising New Approach

A leading cause of vision loss involves the abnormal formation of new blood vessels, a process called "neovascularization." In total, 2 to 3 million Americans suffer vision loss from neovascular eye disease. These include elderly patients with age-related macular degeneration (ARMD), patients with diabetes who suffer from diabetic retinopathy (DR), and infants born with a condition called retinopathy of prematurity (ROP).

The problem of abnormal vasculature in the eye develops in response to "ischemia" (decreased blood flow and oxygen delivery due to abnormalities in small blood vessels as seen in diabetes and ROP) and inflammation (usually due to the abnormal deposition of angiogenic protei
'"/>

Contact: Keith McKeown
kmckeown@scripps.edu
858-784-8134
Scripps Research Institute
30-May-2007


Page: 1 2 3 4 5

Related medicine news :

1. Synthetic production of potential pharmaceuticals dramatically simplified by Scripps research team
2. Scripps research combination therapy obliterates new vessel growth in tumors and retinopathy
3. The Scripps Research Institute, McDonalds align to fight childhood obesity and type 2 diabetes
4. Scripps research team reverses Friedreichs ataxia defect in cell culture
5. Scripps research scientists test anti-obesity vaccine
6. Researchers suggest TB screening for all international adoptees
7. Researchers find vitamin B1 deficiency key to vascular problems for diabetic patients
8. Researchers link metal ions to neurodegenerative disease
9. RAND presents first Victor Fuchs Research Award to economists at Carnegie Mellon University
10. Wesley Research Institute study targets pharmacists to help diabetes sufferers
11. Researchers develop criteria to detect bone mass deficiencies in children with chronic diseases

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/14/2019)... ... September 14, 2019 , ... GreenTheVoteOk , one ... time and again tried to bring the most relevant and important developments in the ... on an increasingly large number of people across the world suffering from different difficult-to-treat ...
(Date:9/11/2019)... , ... September 11, 2019 , ... ... although many industries have struggled to solve injury risks which lead to musculoskeletal ... the wearable technology solution developed by the team at Soter Analytics ...
(Date:9/11/2019)... ... September 11, 2019 , ... The 2019 Minnesota ... Minneapolis at the Mall of America Radisson Blu. Four experts from Twin Cities ... the high-profile, knee-focused conference, which brings together more than 100 national and international ...
(Date:9/11/2019)... ... 2019 , ... Autopsies don’t lie. They report the causes of death ... permanently harms the heart. It increases risks of heart attack and death. ... the damage occurs. , An August 1, 2019 article in U.S. ...
(Date:9/11/2019)... ... September 11, 2019 , ... Executives at health systems and hospitals ... the healthcare industry over the past several years has been intense. For professionals and ... of healthcare in America will depend largely on how these executives respond. Will they ...
Breaking Medicine News(10 mins):
(Date:9/14/2019)... BOSTON (PRWEB) , ... September 13, 2019 , ... ... provider of teledentistry services for employers, became the first commercial teledentistry practice in ... an award-winning startup with other hub entrepreneurs, company leaders, innovators and industry experts ...
(Date:9/14/2019)... ... ... The Allergenic Products Advisory Committee of the Food and Drug Administration (FDA) ... approval of a standardized oral immunotherapy (OIT) product for peanut allergy. The brand name ... The FDA would require a Risk Evaluation and Mitigation Strategy (REMS) to be developed ...
(Date:9/12/2019)... ... ... Stratosphere Networks will sponsor GRIN2B Foundation’s first cocktail reception fundraiser, Gather ... Kitchen and Social House in Evanston from 6 p.m. to 9 p.m. , Proceeds ... gene on the short arm of the 12th chromosome and is part of a ...
Breaking Medicine Technology:
Cached News: